Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
Thumbnail

FDA approves expanded indication for sacubitril/valsartan

Manufactured by Novartis under the name Entresto, the medication is now also approved for treating HFpEF. 

Heart failure medication may offer relief for patients with COVID-related POTS

Overall, researchers found that ivabradine was a “safe and effective” POTS treatment associated with making significant improvements to patient heart rates and quality of life.

chest pain lung pulmonary embolism

AI spots dozens of missed incidental pulmonary embolism diagnoses at one hospital

The investigation was retrospective, but Duke scientists believe their algorithm could potentially aid radiologists in spotting near-misses in their work.

American College of Cardiology calls for high-risk heart disease patients to be prioritized for COVID-19 vaccination

According to the new recommendation, patients with advanced cardiovascular disease are at an especially high risk of COVID-related complications and need to be vaccinated as quickly as possible. 

The Shockwave Medical M5+ new peripheral intravascular lithotripsy (IVL) catheter cuts procedures times in half and was showed for the first time at the American College of Cardiology (ACC) 2022 meeting. It is designed to break up calcium in heavily calcified arteries to avoid the need for vessel trauma caused by high pressure angioplasty.

Shockwave’s IVL technology gains FDA approval for treating advanced coronary artery disease

Shockwave Medical announced Tuesday, Feb. 16, that intravascular lithotripsy (IVL) has gained FDA approval for the treatment of severely calcified coronary artery disease.

CV Summit Virtual 2021: How COVID-19 has led to lasting changes in cardiovascular care

Some COVID-driven changes will likely remain in place for years to come, according to a presentation at CV Summit Virtual 2021.

Ablation could be ‘a powerful new strategy’ for treating heart failure patients with atrial fibrillation

According to a new study published in Circulation, ablation was associated with numerous benefits over standard drug therapy.

Thumbnail

‘The future of digital health’: Apple Watch uses heart rates to ID COVID-19

A team of Mount Sinai specialists published the study, emphasizing the potential of these technologies to improve patient care in a significant way.

Displaying 2681 - 2688 of 10761

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.